Search Within

Khong Ying Ng

Formats
  1. Meeting Abstract (3)
  2. Journal Article (2)
Groups
  1. Cancer Biology and Genetics Program Faculty (5)
  2. GSK Faculty (5)
  3. Sloan Kettering Institute Faculty (5)
  4. Sloan Kettering Institute Postdocs (5)
  5. Adult Leukemia (3)
  6. Center for Hematologic Malignancies (3)

More Groups

People
  1. Hans Wendel (5)
  2. Carlos Fernandez De Larrea Rodriguez (3)
  3. Eric Smith (3)
  4. Mette Staehr (3)
  5. Renier Brentjens (3)
  6. Terence Purdon (3)

More People

Years
  1. 2022 (1)
  2. 2020 (1)
  3. 2019 (3)
Publications
  1. Blood (1)
  2. Blood Cancer Discovery (1)
  3. Cancer Research (1)
  4. Clinical Lymphoma, Myeloma and Leukemia (1)
  5. Science Translational Medicine (1)
Publishers
  1. American Association for Cancer Research (2)
  2. American Association for the Advancement of Science (1)
  3. American Society of Hematology (1)
  4. Elsevier Inc. (1)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Epigenetic control of tumor cell killing by natural killer cells
    Meeting Abstract

    Pasion, J.; Barisic, D.; Meydan, C.; Ng, K. Y.; Lafoz, M. T.; Huse, M.; Melnick, A.; Wendel, H. G.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Defining an optimal dual-targeted CAR T-cell therapy approach simultaneously targeting BCMA and GPRC5D to prevent BCMA escape– Driven relapse in multiple myeloma
    Journal Article

    de Larrea, C. F.; Staehr, M.; Lopez, A. V.; Ng, K. Y.; Chen, Y.; Godfrey, W. D.; Purdon, T. J.; Ponomarev, V.; Wendel, H. G.; Brentjens, R. J.; more...
    Blood Cancer Discovery (2020)

    Fulltext@MSK | Save
  • Optimal dual-targeted CAR construct simultaneously targeting BCMA and GPRC5D prevents BCMA-escape driven relapse in multiple myeloma
    Meeting Abstract

    Fernandez de Larrea, C.; Staehr, M.; Lopez, A.; Chen, Y.; Purdon, T. J.; Ng, K. Y.; Wendel, H.; Brentjens, R. J.; Smith, E. L.
    Blood (2019)

    Fulltext@MSK | Save
  • CAR-directed cytotoxicity of NK cells: An alternative tool to treat and to study multiple myeloma and NK biology
    Meeting Abstract

    Ng, K.; Pasion, J.; Wendel, H. G.
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells
    Journal Article

    Smith, E. L.; Harrington, K.; Staehr, M.; Masakayan, R.; Jones, J.; Long, T. J.; Ng, K. Y.; Ghoddusi, M.; Purdon, T. J.; Wang, X.; more...
    Science Translational Medicine (2019)

    Fulltext@MSK | Save